Form 10-Q - Quarterly report [Sections 13 or 15(d)]

S&P TSX Capped Composite...

US Dollar vs CAD

Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Get Started

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Article too big to display. Click here to view on the SEC website

Q32 Bio (NASDAQ:QTTB)
Historical Stock Chart
From Feb 2025 to Mar 2025

Click Here for more Q32 Bio Charts.

Q32 Bio (NASDAQ:QTTB)
Historical Stock Chart
From Mar 2024 to Mar 2025

Click Here for more Q32 Bio Charts.

Q32 Bio Inc News

Form S-8 - Securities to be offered to employees in employee benefit plans
Tuesday 11 March 2025 (2 days ago) • Edgar (US Regulatory)

Form 424B3 - Prospectus [Rule 424(b)(3)]
Tuesday 11 March 2025 (2 days ago) • Edgar (US Regulatory)

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Tuesday 11 March 2025 (2 days ago) • Edgar (US Regulatory)

Form 8-K - Current report
Tuesday 11 March 2025 (2 days ago) • Edgar (US Regulatory)

Q32 Bio Reports Fourth Quarter 2024 Financial Results and Provides Corporate Update
Tuesday 11 March 2025 (2 days ago) • PR Newswire (US)

Form 424B3 - Prospectus [Rule 424(b)(3)]
Monday 10 March 2025 (3 days ago) • Edgar (US Regulatory)

Form 8-K - Current report
Monday 10 March 2025 (3 days ago) • Edgar (US Regulatory)

Q32 Bio Presents Results from SIGNAL-AA Part A Clinical Trial Evaluating Bempikibart in Patients with Alopecia Areata at the 2025 American Academy of Dermatology Meeting
Saturday 8 March 2025 (5 days ago) • PR Newswire (US)

Q32 Bio Announces Late-Breaking Presentation of Results from SIGNAL-AA Part A Clinical Trial of Bempikibart in Alopecia Areata at the 2025 American Academy of Dermatology Annual Meeting
Friday 28 February 2025 (2 weeks ago) • PR Newswire (US)

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 26 February 2025 (2 weeks ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 26 February 2025 (2 weeks ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 26 February 2025 (2 weeks ago) • Edgar (US Regulatory)

More Q32 Bio Inc News Articles

IT0005626004 20251201 30

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions